Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05395390 · ClinicalTrials.gov registry record · NA

COPD Circuit Exercise

A NA study, sponsored by Texas A&M University.

Completed
Registry status
NA
Development phase
72
Enrollment target

NCT05395390: Completed NA study, sponsored by Texas A&M University.

NCT05395390 is a NA study that has completed, run by Texas A&M University. The registered enrollment target is 72 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05395390, a NA study, has completed, sponsored by Texas A&M University.

COMPLETED
Registry status
NA
Development phase
72 participants
Enrollment target

Study Summary

This study is being done to understand body's response to hybrid home-based and on-site rehabilitation program utilizing individually tailored exercises throughout a total of 18 sessions with 12 of them occurring onsite, in people with and without chronic respiratory diseases, such as Chronic Obstructive Pulmonary Disease (COPD) and Obstructive Sleep Apnea (OSA) and in individuals recovered from COVID-19. Exercise training programs vary widely for people with COPD, OSA, and during prolonged recovery from COVID infection. This study will help identify if this program is helpful to address muscle loss and fatigue specifically in populations with and without chronic respiratory diseases.

Primary Outcome

Whole-body production rate measured after stable tracer administration

Interventions

  • BEHAVIORAL Exercise (Resistance Training

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2021-02-02
Est. Completion 2023-08-07
Phase NA
Texas A&M University

95 total trials

What the finished NCT05395390 record still lists

NCT05395390 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 1 intervention - of which Exercise (Resistance Training is the first listed.

NCT05395390 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05395390 about?

NCT05395390 is a clinical study titled "COPD Circuit Exercise". This study is being done to understand body's response to hybrid home-based and on-site rehabilitation program utilizing individually tailored exercises throughout a total of 18 sessions with 12 of them occurring onsite, in people with and without chronic respiratory diseases, such as Chronic Obstru...

What is the current status of trial NCT05395390?

This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2021-02-02. Estimated completion is 2023-08-07.

What interventions are being tested in trial NCT05395390?

The interventions under investigation include: Exercise (Resistance Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT05395390?

This trial is sponsored by Texas A&M University, which has 95 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05395390's enrollment target sits among peer trials

72 1089th of 2000 higher than 899 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02359253 · 72 participants · NA

    Robot Aided Rehabilitation - Intervention

  • NCT02962661 · 72 participants · Phase 1

    Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

  • NCT03113643 · 72 participants · Phase 1

    SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

  • NCT03187535 · 72 participants · NA

    Effect of TEAS on PONV After Spinal Surgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05395390, the US trial registry maintained by the National Library of Medicine. NCT05395390 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.